Sudeep Pharma Share Price in Focus as Goldman Sachs Acquires 1.04 Percent Stake Worth Rs 100 Crore From Nuvama Funds on 5 August 2026

Sudeep Pharma share price Rs 850 on 5 Aug 2026. Goldman Sachs buys 11.76L shares (1.04% stake) for Rs 100 cr. Nuvama Crossover Fund sells.

The Sudeep Pharma share price is in the spotlight on 5 August 2026 after Goldman Sachs Funds through Goldman Sachs India Equity Portfolio acquired 11.76 lakh shares, representing a 1.04 percent stake, in the company from Nuvama Crossover Opportunities funds for Rs 100 crore at Rs 850 per share. The Sudeep Pharma stock at Rs 850 is now the key institutional reference level, as Goldman Sachs entry at this Sudeep Pharma is a significant development for a company that was previously held primarily by domestic PE fund Nuvama. The Rs 100 crore ticket size makes this one of the larger bulk deal transactions in the pharma space today.

Click Here – Get Free Investment Predictions

Goldman Sachs Entry Into the Sudeep Pharma Share Price

Goldman Sachs India Equity Portfolio is part of the Goldman Sachs Asset Management platform and represents sophisticated global institutional capital entering the Sudeep Pharma share price at Rs 850. Goldman Sachs buying a 1.04 percent stake in Sudeep Pharma at this Sudeep Pharma stock level is a strong institutional validation of the company quality and growth outlook. Global fund houses like Goldman Sachs typically enter mid-cap and small-cap pharma companies when they see a clear earnings growth trajectory, and the Sudeep Pharma entry level of Rs 850 per share reflects this assessment.

The Sudeep Pharma share price transaction saw Nuvama Crossover Opportunities Series III sell 6.14 lakh shares and Series IIIA offload 5.62 lakh shares at Rs 850 per share. As per the June 2026 shareholding pattern, Nuvama Crossover Series III held 2.95 percent and Series IIIA held 2.57 percent of Sudeep Pharma. The exit of Nuvama Crossover at the Sudeep Pharma stock of Rs 850 may reflect successful returns on a PE investment at maturity, rather than any fundamental concern about the Sudeep Pharma outlook.

Sudeep Pharma Share Price: Company Context

Sudeep Pharma operates in the active pharmaceutical ingredients and finished dosage forms space. The Sudeep Pharma share price reflects the company position in the India pharma export and domestic market ecosystem. API companies like Sudeep Pharma benefit from strong global demand for Indian-manufactured pharmaceutical ingredients, cost advantages in manufacturing, and regulatory certifications from USFDA, EUGMP, and other agencies that open export markets.

The Nifty Pharma index has been on an upward trend in 2026, which provides a favourable sector backdrop for the Sudeep Pharma share price. Goldman Sachs entry into the Sudeep Pharma stock at Rs 850 suggests that global investors see the pharma sector rally as having further room to run, particularly for quality API and formulation companies like Sudeep Pharma.

Explore Sudeep Pharma and Pharma Sector Stocks on the Univest Screener

Sudeep Pharma Share Price: What Investors Should Monitor

The key metrics for the Sudeep Pharma share price going forward include quarterly revenue from APIs and formulations, EBITDA margin trajectory, any new regulatory approvals or audit observations from global agencies, and the company export order pipeline. The Sudeep Pharma stock at Rs 850 now has Goldman Sachs as a significant shareholder, which often brings improved research coverage and institutional analyst attention that can further support the Sudeep Pharma over the medium term.

Investors should also watch whether Goldman Sachs India Equity Portfolio increases its Sudeep Pharma share price exposure in subsequent quarters, which would signal sustained conviction in the stock. Any incremental buying at the Sudeep Pharma stock could provide further positive momentum, while any significant selling would be a caution signal.

Download the Univest iOS App or Univest Android App to track the Sudeep Pharma share price and pharma sector bulk deals on Univest.

Conclusion

The Sudeep Pharma share price is in focus on 5 August 2026 as Goldman Sachs acquires a 1.04 percent stake worth Rs 100 crore at Rs 850 per share from Nuvama Crossover funds. This high-profile global institutional entry at the Sudeep Pharma stock is a strong positive signal for the company and the broader pharma sector. Investors tracking the Sudeep Pharma should follow quarterly earnings, export pipeline updates, and any further Goldman Sachs activity in the stock as key indicators of near-term direction.

Frequently Asked Questions

What is the Sudeep Pharma share price today?

Ans. The Sudeep Pharma share price on 5 August 2026 was Rs 850 per share, the level at which Goldman Sachs India Equity Portfolio acquired 11.76 lakh shares from Nuvama Crossover Opportunities funds.

Why did Goldman Sachs buy the Sudeep Pharma stake?

Ans. Goldman Sachs India Equity Portfolio entered the Sudeep Pharma share price at Rs 850 per share, acquiring a 1.04 percent stake for Rs 100 crore. Global fund houses typically buy at the Sudeep Pharma stock level when they see strong earnings growth and sector tailwinds in the Indian pharma space.

Who sold the Sudeep Pharma shares to Goldman Sachs?

Ans. Nuvama Crossover Opportunities Fund Series III sold 6.14 lakh shares and Series IIIA sold 5.62 lakh shares at Rs 850 per share, totalling 11.76 lakh Sudeep Pharma shares at the current Sudeep Pharma share price.

What does Sudeep Pharma do?

Ans. Sudeep Pharma manufactures active pharmaceutical ingredients and finished dosage forms. The Sudeep Pharma share price is influenced by its API export performance, regulatory certifications from global agencies, and the broader Indian pharma sector growth trajectory.

What does Goldman Sachs entry mean for the Sudeep Pharma share price?

Ans. Goldman Sachs entry into the Sudeep Pharma share price at Rs 850 is a strong institutional validation signal. Global fund involvement often brings improved research coverage and sustained institutional interest, which can support the Sudeep Pharma stock over the medium term.

Where can I track the Sudeep Pharma share price?

Ans. The Sudeep Pharma share price can be tracked on NSE and BSE official websites. Use the Univest app and screener for live Sudeep Pharma stock data, bulk deal alerts, and pharma sector analysis.